Cargando…
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
On March 11, 2020, the World Health Organization (WHO) declared the severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2) a global pandemic. As of July 2020, SARS-CoV-2 has infected more than 14 million people and provoked more than 590,000 deaths, worldwide. From the beginning, a v...
Autores principales: | Lisi, Lucia, Lacal, Pedro Miguel, Barbaccia, Maria Luisa, Graziani, Grazia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375972/ https://www.ncbi.nlm.nih.gov/pubmed/32710969 http://dx.doi.org/10.1016/j.bcp.2020.114169 |
Ejemplares similares
-
Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020) -
Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib
por: Atzori, Maria Grazia, et al.
Publicado: (2019) -
Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action()
por: Yousefi, Hassan, et al.
Publicado: (2021) -
Perspectives for repurposing drugs for the coronavirus disease 2019
por: Cherian, Sarah S., et al.
Publicado: (2020) -
Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections
por: Schwartz, David A., et al.
Publicado: (2020)